101 filings
Page 5 of 6
8-K
yl5w8 lok9o
12 Apr 17
Biotricity Files for its Second and Final FDA 510(k) to Bring Bioflux Solution to Market
12:00am
8-K
9ae8uzas6zx
6 Apr 17
Entry into a Material Definitive Agreement
12:00am
8-K/A
f6io3bi7
29 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
yzav8zjz31vbl8sy
9 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
y2vjp6 smmurjg
23 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
fa9ysmc1547fn5f13m
5 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
gikdz8
7 Nov 16
Other Events
12:00am
8-K
cugyve3n8g
3 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
70bxxoz16es4rgm5aew
18 Oct 16
Other Events
12:00am
8-K
tqjd9mgatnv7 0t
12 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
lnb2cf ow
12 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
v4llpu
4 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
ij7iyxer7u 0sqruz6
20 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
ibksnl8c6fj5a4azwy2
19 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
h5mtdsjui9qxi
17 May 16
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
cpw3g8m
3 May 16
Biotricity Appoints Norman Betts to Board of Directors
12:00am
8-K
f8jggb 6omjlaqiz
14 Apr 16
Entry into a Material Definitive Agreement
12:00am
8-K/A
q0dp8 ctv5uk2co
13 Apr 16
Completion of Acquisition or Disposition of Assets
12:00am
8-K
zofr7g
6 Apr 16
Entry into a Material Definitive Agreement
12:00am
8-K
0lu8tlri0lrel6f
3 Feb 16
Unaudited Pro Forma Combined Financial Statements
12:00am